An Evaluation of the Tumor Microenvironment through CALR,IL1R1,IFNB1,and IFNG to Assess Prognosis and Immunotherapy Response in Bladder Cancer Patients
L. Lilong, L. Zhenghao, F. Lei, Y. Zhipeng, H. Junyi, H. Yaxin, L. Yang, D. Yuhong, K. Yingchun, C. Ke, H. Yi, L. Zheng
This study evaluates ICD-related genes in bladder cancer to assess prognosis and immunotherapy response, finding higher ICD expression correlates with better survival and response to PD1-targeted therapy.
bioRxiv · Jan 24, 2024 · PreprintImmunology